Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Jagsonpal Pharmaceuticals Ltd. ( (IN:JAGSNPHARM) ) is now available.
Jagsonpal Pharmaceuticals has allotted 71,800 equity shares of Rs. 2 each to eligible employees under its Employee Stock Option Plan 2022, following the exercise of vested options. The newly issued shares, priced at an exercise rate of Rs. 94 with a premium of Rs. 92, rank pari passu with existing equity and carry the same rights as current shareholders.
With this allotment, the company’s paid-up share capital has increased from Rs. 13.37 crore to Rs. 13.39 crore, raising the total number of outstanding shares to 6,69,62,250. The move marginally dilutes existing holdings but underscores Jagsonpal’s use of stock-based compensation to incentivize and retain key employees, aligning their interests with long-term shareholder value.
More about Jagsonpal Pharmaceuticals Ltd.
Jagsonpal Pharmaceuticals Ltd. is an Indian pharmaceutical company listed on BSE and NSE, operating from registered offices in New Delhi and corporate offices in Gurugram and Mumbai. The company is engaged in manufacturing and marketing pharmaceutical products, serving domestic and possibly international healthcare markets through its listed equity structure.
Average Trading Volume: 6,795
Technical Sentiment Signal: Hold
Current Market Cap: 11.65B INR
For detailed information about JAGSNPHARM stock, go to TipRanks’ Stock Analysis page.